Acronym/Abbreviation | Name |
ACTG | AIDS Clinical Trials Group |
ADVANCE | Assessing Donor Variability And New Concepts in Eligibility |
ARDENT | ACTG A5257 trial |
ARTEMIS | Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study |
ATLAS | Antiretroviral Therapy as Long-Acting Suppression |
D:A:D | Data Collection on Adverse Events of Anti-HIV Drugs |
ECHO | Evidence for Contraceptive Options in HIV |
ENCORE | Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy |
FLAIR | First Long-Acting Injectable Regimen |
FLAMINGO | Dolutegravir Compared to Darunavir/Ritonavir, Each in Combination With Dual Nucleoside ReverseTranscriptase Inhibitors |
HPTN | HIV Prevention Trials Network |
NADIA | Nucleosides And Darunavir/Dolutegravir In Africa |
NAMSAL | New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries |
STaR | Single-Tablet Regimen |
START | Strategic Timing of AntiRetroviral Trea |
Australian Commentary to the US DHHS Guidelines for the use of Antiretroviral Agents in Adults and Adolescents with HIV
US DHHS Guidelines with Australian Commentary
To visit the Pediatric Antiretroviral Guidelines, visit this link.
Menu
ARV Guidelines > Adult Guidelines > Appendix A: Key to Acronyms > Study and Trial Names
Table of Contents
Menu